Julia Reichelt

8PUBLICATIONS
19CO-AUTHORS
Molecular targetsCancer geneticsMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 11, 2022
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer.

Katharina Woess, Yuchen Sun, Hanae Morio

|Sep 12, 2020
Gene expression is stable in a complete CIB1 knockout keratinocyte model.

Elias Imahorn, Magomet Aushev, Stefan Herms

|May 30, 2019
Epidermolysis bullosa: Advances in research and treatment.

Christine Prodinger, Julia Reichelt, Johann W Bauer

|Sep 09, 2018
Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.

Christina Guttmann-Gruber, Birgit Tockner, Cornelia Scharler

|Aug 13, 2018
An ex vivo RNA trans-splicing strategy to correct human generalized severe epidermolysis bullosa simplex.

P Peking, J S Breitenbach, M Ablinger

|Mar 10, 2018
RNA Trans-Splicing Modulation via Antisense Molecule Interference.

Bernadette Liemberger, Josefina Piñón Hofbauer, Verena Wally

Pageof 2

Frequent Collaborators

2 joint publications

Verena Wally

2 joint publications

Ulrich Koller

1 joint publications

P Peking

1 joint publications

M Schmuth